Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001583742-16-000002

CEO & President acquired 142,857,143 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hakim Nasrat A CEO & President 2016-08-17 Option exercise +142,857,143 142,971,097 I
Derivatives
Hakim Nasrat A CEO & President 2016-08-17 Option exercise · Series I Convertible Preferred Shares −100 0 I
Loading xslF345X03/primary_doc.xml…